Biology Reference
In-Depth Information
References
1. Cunliffe NA, Nakagomi O. (2005) A critical time for rotavirus vac-
cines: a review.
Expert Rev Vacc
4
(4): 521-532.
2. Girard MP, Cherian T, Pervikov Y, Kieny MP. (2005) A review of vac-
cine research and development: human acute respiratory infections.
Vaccine
23
(50): 5708-5724.
3. Hartaningsih N, Dharma DM, Soeharsono S, Wilcox GE. (2001) The
induction of a protective immunity against Jembrana disease in cattle
by vaccination with inactivated tissue-derived virus antigens.
Ve t
Immunol Immunopathol
78
(2): 163-176.
4. LaBrecque FD, LaBrecque DR, Klinzman D,
et al
. (1998)
Recombinant hepatitis A virus antigen: improved production and util-
ity in diagnostic immunoassays.
J Clin Microbiol
36
(7): 2014-2018.
5. McLean AA. (1986) Development of vaccines against hepatitis A and
hepatitis B.
Rev Infect Dis
8
(4): 591-598.
6. Schwarz TF, Roggendorf M. (1990) Diagnostic of parvovirus B19
infection.
Behring Inst Mitt
85
: 35-38.
7. Scott RM, Nisalak A, Cheamudon U,
et al
. (1980) Isolation of dengue
viruses from peripheral blood leukocytes of patients with hemorrhagic
fever.
J Infect Dis
141
(1): 1-6.
8. Swayne DE. (2004) Application of new vaccine technologies for the
control of transboundary diseases.
Dev Biol (Basel)
119
: 219-228.
9. Szmuness W, Stevens CE, Harley EJ,
et al
. (1980) Hepatitis B
vaccine: demonstration of efficacy in a controlled clinical trial in a
high-risk population in the United States.
N Engl J Med
303
(15):
833-841.
10. Wood JM, Robertson JS. (2004) From lethal virus to life-saving vac-
cine: developing inactivated vaccines for pandemic influenza.
Nat Rev
Microbiol
2
(10): 842-847.
11. Wu JJ, Huang DB, Pang KR, Tyring SK. (2004) Vaccines and
immunotherapies for the prevention of infectious diseases having cuta-
neous manifestations.
J Am Acad Dermatol
50
(4): 495-528.
12. Bukhari NI, Aziz MT, Jamshaid M. (2005) Comparative immuno-
genicity of a genetically derived and a plasma pooled hepatitis B vac-
cine in normal adult volunteers.
Therapie
60
(3): 311-316.
13. Yap SF. (2004) Hepatitis B: review of development from the discovery
of the “Australia Antigen” to end of the twentieth Century.
Malays
J Pathol
26
(1): 1-12.
